Results 101 to 110 of about 7,642 (118)

[Recent advances in individualized treatment for pediatric high-risk B-cell acute lymphoblastic leukemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Li YQ, Wang YJ, Li ZZ, Ni JX.
europepmc   +1 more source

[Mechanisms and clinical research progress of mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang N, Xu ZL, Liu DH.
europepmc   +1 more source

[Pathogen Profile and Risk Factors for Hospital-Acquired Infection in Stroke Patients]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Xu T, Han B, Zhang H, Shao C, Wang Y, Jiao Y, Zhang G.   +6 more
europepmc   +1 more source

[Advances in ribosome biogenesis and targeted therapies for diffuse large B-cell lymphomas]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Yue MX, Zhao WL, Wang L.
europepmc   +1 more source

[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang M, Zhang FN, Gong H, Liu CC, Zhao TT, He N.   +5 more
europepmc   +1 more source

[Antibacterial activity and mechanism of the antiparasitic drug resorantel against <i>Staphylococcus epidermidis</i>]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Guo S, Huang G, Xiao D, Lu L, Li M, Li Y, Wu Y.   +6 more
europepmc   +1 more source

[Efficacy and safety of rituximab in children with refractory nephrotic syndrome]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Bai W, Xu K, Su BG, Liu XY, Zhong XH, Xiao HJ, Yao Y, Zhang HW, Wang F.   +8 more
europepmc   +1 more source

[Evolving treatment landscape of pediatric acute leukemia: integration and breakthroughs in immunotherapy and targeted therapy]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wen FQ, Mai HR.
europepmc   +1 more source

[Perinatal tuberculosis presenting as endobronchial tuberculosis diagnosed by bronchoscopy: a case report]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Wu H, Lin Y, Tao X, Wu L.
europepmc   +1 more source

[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2026)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Myeloma Committee-Chinese Hematology Association.   +3 more
europepmc   +1 more source